Schedule 13G ownership disclosure
KINNATE BIOPHARMA INC
Security class unavailable · CUSIP: 49705R105
Event date: 2023-01-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,213,178
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-000541
- Form type
- SC 13G
- Filer
- Kinnate Biopharma Inc.
- CIK
- CIK 1797768
- Filed
- Jan 23, 2023
- Reporting period
- Jan 13, 2023
- Description
- Schedule 13G beneficial ownership